Arvee Laboratories India Ltd vs Multibase India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Arvee Laboratories (India) Ltd is ₹ 150 as of 18 Mar 15:30 . The P/E Ratio of Arvee Laboratories (India) Ltd changed from 22.8 on March 2021 to 72.8 on March 2025 . This represents a CAGR of 26.14% over 5 yearsThe P/E Ratio of Multibase India Ltd changed from 35.9 on March 2021 to 23.6 on March 2025 . This represents a CAGR of -8.05% over 5 years The Market Cap of Arvee Laboratories (India) Ltd changed from ₹ 61.05 crore on March 2021 to ₹ 156.47 crore on March 2025 . This represents a CAGR of 20.71% over 5 yearsThe Market Cap of Multibase India Ltd changed from ₹ 241.29 crore on March 2021 to ₹ 346.17 crore on March 2025 . This represents a CAGR of 7.49% over 5 years The revenue of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 9.92 crore as compare to the Sep '25 revenue of ₹ 3.68 crore. This represent the growth of 169.57% The revenue of Multibase India Ltd for the Dec '25 is ₹ 14.37 crore as compare to the Sep '25 revenue of ₹ 19.3 crore. This represent the decline of -25.54% The ebitda of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 1.76 crore as compare to the Sep '25 ebitda of ₹ 0.36 crore. This represent the growth of 388.89% The ebitda of Multibase India Ltd for the Dec '25 is ₹ 4.7 crore as compare to the Sep '25 ebitda of ₹ 4.15 crore. This represent the growth of 13.25% The net profit of Arvee Laboratories (India) Ltd changed from ₹ 0.94 crore to ₹ 1.83 crore over 7 quarters. This represents a CAGR of 46.33% The net profit of Multibase India Ltd changed from ₹ 3.92 crore to ₹ 3.28 crore over 7 quarters. This represents a CAGR of -9.68% The Dividend Payout of Arvee Laboratories (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Multibase India Ltd changed from 37.56 % on March 2021 to 456.56 % on March 2025 . This represents a CAGR of 64.80% over 5 years .

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat.
Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017.
Presently, the Company is engaged in manufacturing of specialized chemicals. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association.
Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013.

About Multibase India Ltd

Multibase India Limited was incorporated as Synergy Polymers Limited on 17th December, 1991.
In 1999, the name of Company was changed to Synergy Mulitibase Limited and further to Multibase India Limited on August 31, 2007. Multibase India Ltd is part of the Multibase SA Group, a leading compounder in Europe, the USA and India.
In 2002, the Company was acquired by Multibase SA, subsidiary of Dow Corning Corporation and thus became a Dow corning Company. The company is engaged in in manufacturing, trading and selling of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master batch.
It is a diverse yet integrated manufacturing company of thermoplastic elastomers and silicone-based products. The Company's products include Silicon-Based Thermoplastics, TPSiV Multiplex, Thermoplastic-Elastomer (TPE physically blends), Triethyl silane (TES) Multiplex Range of Products.

FAQs for the comparison of Arvee Laboratories (India) Ltd and Multibase India Ltd

Which company has a larger market capitalization, Arvee Laboratories (India) Ltd or Multibase India Ltd?

Market cap of Arvee Laboratories (India) Ltd is 165 Cr while Market cap of Multibase India Ltd is 358 Cr

What are the key factors driving the stock performance of Arvee Laboratories (India) Ltd and Multibase India Ltd?

The stock performance of Arvee Laboratories (India) Ltd and Multibase India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Arvee Laboratories (India) Ltd and Multibase India Ltd?

As of March 18, 2026, the Arvee Laboratories (India) Ltd stock price is INR ₹150.0. On the other hand, Multibase India Ltd stock price is INR ₹283.8.

How do dividend payouts of Arvee Laboratories (India) Ltd and Multibase India Ltd compare?

To compare the dividend payouts of Arvee Laboratories (India) Ltd and Multibase India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.